Allspring Global Investments
CLPT icon

Allspring Global Investments’s ClearPoint Neuro CLPT Stock Holding History

Allspring Global Investments’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,465
Closed -$22.4K – 2319
2023
Q3 		$22.4K Buy
+4,465
New +$26.6K ﹤0.01% 2486
2022
Q2 		– Sell
-2,128
Closed -$22K – 2731
2022
Q1 		$22K Sell
2,128
-282
-12% -$2.57K ﹤0.01% 2933
2021
Q4 		$27K Buy
+2,410
New +$36.1K ﹤0.01% 2888

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allspring Global Investments's CLPT Position: Q4 2023 in Review

Allspring Global Investments sold out of ClearPoint Neuro (CLPT) in Q4 2023, closing a stake of 4,465 shares — an estimated $22.4K sold.

Allspring Global Investments first reported a position in CLPT in Q4 2021 and held it in 3 quarters. The position peaked at $27K in Q4 2021. 71 funds tracked by Wall St. Rank hold CLPT as of Q4 2023.

  • Allspring Global Investments reported no remaining ClearPoint Neuro position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 4,465 ClearPoint Neuro shares in Q4 2023, an estimated $22.4K.
  • Allspring Global Investments first reported a position in ClearPoint Neuro in Q4 2021 and held it in 3 quarters.
  • Allspring Global Investments's ClearPoint Neuro position peaked at $27K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.